Skip to main content
Top
Published in: BMC Complementary Medicine and Therapies 1/2021

Open Access 01-12-2021 | Antibiotic | Research article

Antimicrobial activity of medicinal plants used for urinary tract infections in pastoralist community in Ethiopia

Authors: Eshetu Gadisa, Elazar Tadesse

Published in: BMC Complementary Medicine and Therapies | Issue 1/2021

Login to get access

Abstract

Background

Medicinal plants have wide medicament application used to prevent and management of many ailments. These plants are used for primary health care in pastoralist communities who are deprived of modern medical care. They possess extensive therapeutics bioactive coupled with varied chemical structures. However, scientific validation of efficacy and safety of plants used to treat the urinary tract infections haven’t been fully exploited. The aim of this study was to evaluate antimicrobial activity and screening phytochemicals of medicinal plants used to treat urinary tract infections.

Methods

In-vitro experimental study was carried out to evaluate the antimicrobial effect and screening phytochemical of Rumex abyssinicus, Cucumis pustulatus, Discopodium penninervium, Lippia adoensis, Euphorbia depauperata, and Cirsium englerianum. Against drug resistance microbes. 80% methanol was used for extraction of the plant parts. The susceptibility tests were investigated using disc diffusion and broth micro-dilution methods.

Results

The majority of tested extracts showed antimicrobial activity on two or more drug-resistant bacteria with MIC value (1.0–128.0 μg/ml) and 9–27 mm inhibition zone in diameter. Extracts obtained from C.englerianum and E. depauperate showed more potent antibacterial activity on MRSA and Enterococcus faecalis with IZ 25 and 27 mm respectively. E. coli and K. pneumoniae were inhibited by those extracts with IZ ranging 9–25 mm and 11–27 mm respectively. E.faecalis and K. pneumoniae were more susceptible bacteria to the respective extracts. R. abyssinicus showed promising antifungal effect with had 21 mm IZ and MIC range 16-32 μg/ml on C.albicans. Alkaloids, flavonoids, phenolic and terpenoid were common phytochemical characterized in majority of screened plants.

Conclusion

Tested extracts exhibited significant antibacterial and antifungal activity. Hence, further structural elucidation of bioactive that inhibited the growth of microbes aforementioned plants may be used as precursors for the synthesis of new antibiotics in the future.
Literature
1.
go back to reference Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25–64.CrossRef Fair RJ, Tor Y. Antibiotics and bacterial resistance in the 21st century. Perspect Medicin Chem. 2014;6:25–64.CrossRef
2.
go back to reference Lafon T, Hernandez Padilla AC, Baisse A, et al. Community-acquired S aureus bacteriuria: A warning microbiological marker for infective endocarditis. BMC Infect Dis. 2019;19:504.CrossRef Lafon T, Hernandez Padilla AC, Baisse A, et al. Community-acquired S aureus bacteriuria: A warning microbiological marker for infective endocarditis. BMC Infect Dis. 2019;19:504.CrossRef
3.
go back to reference Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari Cheshmeh M, Salehian OD. Urinary tract infections associated with C. albicans. Maedica. 2010;5(4):277–9.PubMedPubMedCentral Behzadi P, Behzadi E, Yazdanbod H, Aghapour R, Akbari Cheshmeh M, Salehian OD. Urinary tract infections associated with C. albicans. Maedica. 2010;5(4):277–9.PubMedPubMedCentral
4.
go back to reference Heintz BH, Halilovic J, Christensen CL. Vancomycin-resistant enterococcal urinary tract infections. Pharmacotherapy. 2010;30(11):1136–49.CrossRef Heintz BH, Halilovic J, Christensen CL. Vancomycin-resistant enterococcal urinary tract infections. Pharmacotherapy. 2010;30(11):1136–49.CrossRef
5.
go back to reference Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. Colonization with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and MRSA in a long-term care facility over one year. BMC Infect Dis. 2015;15:168.CrossRef Ludden C, Cormican M, Vellinga A, Johnson JR, Austin B, Morris D. Colonization with ESBL-producing and carbapenemase-producing Enterobacteriaceae, vancomycin-resistant enterococci, and MRSA in a long-term care facility over one year. BMC Infect Dis. 2015;15:168.CrossRef
6.
go back to reference Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V. Inhibiting bacterial drug efflux pumps via phyto-therapeutics tocombat threatening antimicrobial resistance. Front Microbiol. 2018;9:2990.CrossRef Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V. Inhibiting bacterial drug efflux pumps via phyto-therapeutics tocombat threatening antimicrobial resistance. Front Microbiol. 2018;9:2990.CrossRef
7.
go back to reference Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019;26(8):taz036. Frost I, Van Boeckel TP, Pires J, Craig J, Laxminarayan R. Global geographic trends in antimicrobial resistance: the role of international travel. J Travel Med. 2019;26(8):taz036.
8.
go back to reference Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–18.CrossRef Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309–18.CrossRef
9.
go back to reference Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–310.CrossRef Dadgostar P. Antimicrobial resistance: implications and costs. Infect Drug Resist. 2019;12:3903–310.CrossRef
10.
go back to reference Brown E, Wright G. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336–43.CrossRef Brown E, Wright G. Antibacterial drug discovery in the resistance era. Nature. 2016;529:336–43.CrossRef
11.
go back to reference WHO. Global report on traditional and complementary medicine 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO WHO. Global report on traditional and complementary medicine 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO
12.
go back to reference Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev. 2017;117(19):12415–74.CrossRef Rossiter SE, Fletcher MH, Wuest WM. Natural products as platforms to overcome antibiotic resistance. Chem Rev. 2017;117(19):12415–74.CrossRef
13.
go back to reference Gadisa E, Weldearegay G, Desta K, et al. Combined antibacterial effect of essential oils from three most commonly used Ethiopian traditional medicinal plants on multidrug resistant bacteria. BMC Complement Altern Med. 2019;19(1):24.CrossRef Gadisa E, Weldearegay G, Desta K, et al. Combined antibacterial effect of essential oils from three most commonly used Ethiopian traditional medicinal plants on multidrug resistant bacteria. BMC Complement Altern Med. 2019;19(1):24.CrossRef
14.
go back to reference Khameneh B, Iranshahy M, Soheili V, et al. Review on plant antimicrobials: a mechanistic viewpoint. Antimicrob Resist Infect Control. 2019;8:118.CrossRef Khameneh B, Iranshahy M, Soheili V, et al. Review on plant antimicrobials: a mechanistic viewpoint. Antimicrob Resist Infect Control. 2019;8:118.CrossRef
15.
go back to reference Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing E. coli and K. pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect. 2011;44(5):364–8.CrossRef Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing E. coli and K. pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect. 2011;44(5):364–8.CrossRef
16.
go back to reference Shumaia P, Abdul K, Aktar C, Ekramul H. Antibacterial, antifungal and insecticidal activities of the n-hexane and ethyl-acetate fractions of methanolic extract of the leaves of Calotropis gigantea. JPP. 2014;2(5):47–51. Shumaia P, Abdul K, Aktar C, Ekramul H. Antibacterial, antifungal and insecticidal activities of the n-hexane and ethyl-acetate fractions of methanolic extract of the leaves of Calotropis gigantea. JPP. 2014;2(5):47–51.
17.
go back to reference Ohikhena FU, Wintola OA, Afolayan AJ. Evaluation of the antibacterial and antifungal properties of Phragmanthera capitata (Sprengel) Balle (Loranthaceae), a mistletoe growing on rubber tree, using the dilution techniques. Sci World J. 2017;2017:9658598.CrossRef Ohikhena FU, Wintola OA, Afolayan AJ. Evaluation of the antibacterial and antifungal properties of Phragmanthera capitata (Sprengel) Balle (Loranthaceae), a mistletoe growing on rubber tree, using the dilution techniques. Sci World J. 2017;2017:9658598.CrossRef
18.
go back to reference Maheshwari M, Safar Althubiani A, Hasan Abulreesh H, Abul Qais F, Shavez Khan M, Ahmad I. Bioactive extracts of Carum copticum enhances efficacy of ciprofloxacin against MDR enteric bacteria. Saudi J Biol Sci. 2019;26:1848–55.CrossRef Maheshwari M, Safar Althubiani A, Hasan Abulreesh H, Abul Qais F, Shavez Khan M, Ahmad I. Bioactive extracts of Carum copticum enhances efficacy of ciprofloxacin against MDR enteric bacteria. Saudi J Biol Sci. 2019;26:1848–55.CrossRef
19.
go back to reference Tchinda CF, Sonfack G, Simo IK, et al. Antibacterial and antibiotic-modifying activities of fractions and compounds from Albizia adianthifolia against MDR gram-negative enteric bacteria. BMC Complement Altern Med. 2019;19(1):120.CrossRef Tchinda CF, Sonfack G, Simo IK, et al. Antibacterial and antibiotic-modifying activities of fractions and compounds from Albizia adianthifolia against MDR gram-negative enteric bacteria. BMC Complement Altern Med. 2019;19(1):120.CrossRef
20.
go back to reference Tayel AA, Shaban SM, Moussa SH, Elguindy NM, Diab AM, Mazrou KE, El-Sabbagh SM. Bioactivity and application of plant seeds’ extracts to fight resistant strains of S. aureus. Ann Agric Sci. 2018;63(1):47–53.CrossRef Tayel AA, Shaban SM, Moussa SH, Elguindy NM, Diab AM, Mazrou KE, El-Sabbagh SM. Bioactivity and application of plant seeds’ extracts to fight resistant strains of S. aureus. Ann Agric Sci. 2018;63(1):47–53.CrossRef
21.
go back to reference Marathe NP, Rasane MH, Kumar H, Patwardhan AA, Shouche YS, Diwanay SS. In vitro antibacterial activity of Tabernaemontana alternifolia stem bark aqueous extracts against clinical isolates of methicillin resistant S aureus. Ann Clin Microbiol Antimicrob. 2013;12:26.CrossRef Marathe NP, Rasane MH, Kumar H, Patwardhan AA, Shouche YS, Diwanay SS. In vitro antibacterial activity of Tabernaemontana alternifolia stem bark aqueous extracts against clinical isolates of methicillin resistant S aureus. Ann Clin Microbiol Antimicrob. 2013;12:26.CrossRef
22.
go back to reference Saeidi S, Amini Boroujeni N, Ahmadi H, Hassanshahian M. Antibacterial activity of some plant extracts against extended- spectrum beta-lactamase producing E. coli isolates. Jundishapur J Microbiol. 2015;8(2):e15434.CrossRef Saeidi S, Amini Boroujeni N, Ahmadi H, Hassanshahian M. Antibacterial activity of some plant extracts against extended- spectrum beta-lactamase producing E. coli isolates. Jundishapur J Microbiol. 2015;8(2):e15434.CrossRef
23.
go back to reference Terlizzi ME, Gribaudo G, Maffei ME. Uropathogenic E.coli infections: Virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566.CrossRef Terlizzi ME, Gribaudo G, Maffei ME. Uropathogenic E.coli infections: Virulence factors, bladder responses, antibiotic, and non-antibiotic antimicrobial strategies. Front Microbiol. 2017;8:1566.CrossRef
24.
go back to reference Chuah EL, Zakaria ZA, Suhaili Z, Abu Bakar S, MNM D. Antimicrobial activities of plant extracts against MSSA and methicillin-Resistant S. aureus. Int J Microbiol Res. 2014;4(1):6–13. Chuah EL, Zakaria ZA, Suhaili Z, Abu Bakar S, MNM D. Antimicrobial activities of plant extracts against MSSA and methicillin-Resistant S. aureus. Int J Microbiol Res. 2014;4(1):6–13.
25.
go back to reference Gonzalez-Alamilla EN, Gonzalez-Cortazar M, Valladares B,. et al. Chemical constituents os Salix babylonica and their antibacterial activity against gram positive and gram negative animal bacteria. Molecules. 2019;24(16):2992. Gonzalez-Alamilla EN, Gonzalez-Cortazar M, Valladares B,. et al. Chemical constituents os Salix babylonica and their antibacterial activity against gram positive and gram negative animal bacteria. Molecules. 2019;24(16):2992.
26.
go back to reference Aris P, Boroumand MA, Rahbar M, Douraghi M. The activity of fosfomycin against extended-spectrum beta-lactamase-producing isolates of Enterobacteriaceae recovered from urinary tract infections: a single-center study over a period of 12 years. Microb Drug Resist. 2018;24(5):607–12.CrossRef Aris P, Boroumand MA, Rahbar M, Douraghi M. The activity of fosfomycin against extended-spectrum beta-lactamase-producing isolates of Enterobacteriaceae recovered from urinary tract infections: a single-center study over a period of 12 years. Microb Drug Resist. 2018;24(5):607–12.CrossRef
27.
go back to reference Salam AM, Quave CL. Opportunities for plant natural products in infection control. Curr Opin Microbiol. 2018;45:189–94.CrossRef Salam AM, Quave CL. Opportunities for plant natural products in infection control. Curr Opin Microbiol. 2018;45:189–94.CrossRef
28.
go back to reference Varaprased B. A search for antimicrobial agents. In: Pacheco G, Alcantara C, Abreu C, Correa M, editors. Relationship between chemical structure and activity of triterpene against gram positive and gram-negative bacteria. Croatia: In Tech; 2012. p. 2–79. www.intechopen.com. Varaprased B. A search for antimicrobial agents. In: Pacheco G, Alcantara C, Abreu C, Correa M, editors. Relationship between chemical structure and activity of triterpene against gram positive and gram-negative bacteria. Croatia: In Tech; 2012. p. 2–79. www.​intechopen.​com.
29.
go back to reference Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582–614.CrossRef Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, et al. Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv. 2015;33(8):1582–614.CrossRef
30.
go back to reference Katiyar C, Gupta A, Kanjilal S, Katiyar S. Drug discovery from plant sources: an integrated approach. Ayu. 2012;33(1):10–9.CrossRef Katiyar C, Gupta A, Kanjilal S, Katiyar S. Drug discovery from plant sources: an integrated approach. Ayu. 2012;33(1):10–9.CrossRef
31.
go back to reference Wiegand I, Hilpert K, Hancock R. Agar and broth dilution method to determine the MIC of antimicrobial substances. Nat Protoc. 2008;3(2):163–75.CrossRef Wiegand I, Hilpert K, Hancock R. Agar and broth dilution method to determine the MIC of antimicrobial substances. Nat Protoc. 2008;3(2):163–75.CrossRef
32.
go back to reference CLSI. Performance for antimicrobial susceptibility testing: twenty-first informational supplement-M 100-S21. Wayne, PA, USA: CLSI; 2011. CLSI. Performance for antimicrobial susceptibility testing: twenty-first informational supplement-M 100-S21. Wayne, PA, USA: CLSI; 2011.
33.
go back to reference Abdissa D, Geleta G, Bacha K, Abdissa N. Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities. PLoS One. 2017;12(3):e0173882.CrossRef Abdissa D, Geleta G, Bacha K, Abdissa N. Phytochemical investigation of Aloe pulcherrima roots and evaluation for its antibacterial and antiplasmodial activities. PLoS One. 2017;12(3):e0173882.CrossRef
Metadata
Title
Antimicrobial activity of medicinal plants used for urinary tract infections in pastoralist community in Ethiopia
Authors
Eshetu Gadisa
Elazar Tadesse
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Complementary Medicine and Therapies / Issue 1/2021
Electronic ISSN: 2662-7671
DOI
https://doi.org/10.1186/s12906-021-03249-7

Other articles of this Issue 1/2021

BMC Complementary Medicine and Therapies 1/2021 Go to the issue